RESINA LARICIS/ANANASSA COMP GEL DIN 02232627
Status: Cancelled Post Market
Holder: WELEDA AG HEILMITTELBETRIEBE
Molecule: PINEAPPLE
Available to quote
Health Canada record
| Active ingredient(s) | PINEAPPLE 1 D; RESINA LARICIS 1 D |
|---|---|
| Dosage form | Gel |
| Route | Topical |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 06-Apr-1998 |
| Current status date | 05-Sep-2002 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PINEAPPLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02234308 | ANANASSA SATIVA | DOLISOS CANADA INC. | Granules; Liquid; Globules | PINEAPPLE 1 X | Cancelled Post Market |
International API supply for PINEAPPLE
4 active FDA Drug Master Files.
Request a quote for RESINA LARICIS/ANANASSA COMP GEL